Skip to Content

Publication Reprint Request

Title: The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Authors: Sinilnikova OM,  Antoniou AC,  Simard J,  Healey S,  Léoné M,  Sinnett D,  Spurdle AB,  Beesley J,  Chen X,  kConFab,  Greene MH,  Loud JT,  Lejbkowicz F,  Rennert G,  Dishon S,  Andrulis IL,  OCGN,  Domchek SM,  Nathanson KL,  Manoukian S,  Radice P,  Konstantopoulou I,  Blanco I,  Laborde AL,  Durán M,  Osorio A,  Benitez J,  Hamann U,  Hogervorst FB,  van Os TA,  Gille HJ,  HEBON,  Peock S,  Cook M,  Luccarini C,  Evans DG,  Lalloo F,  Eeles R,  Pichert G,  Davidson R,  Cole T,  Cook J,  Paterson J,  Brewer C,  EMBRACE,  Hughes DJ,  Coupier I,  Giraud S,  Coulet F,  Colas C,  Soubrier F,  Rouleau E,  Bièche I,  Lidereau R,  Demange L,  Nogues C,  Lynch HT,  GEMO,  Schmutzler RK,  Versmold B,  Engel C,  Meindl A,  Arnold N,  Sutter C,  Deissler H,  Schaefer D,  Froster UG,  GC-HBOC,  Aittomäki K,  Nevanlinna H,  McGuffog L,  Easton DF,  Chenevix-Trench G,  Stoppa-Lyonnet D,  Consortium of Investigators of Modifiers of BRCA1/2
Journal: Br J Cancer 101(8):1456-60
Date: 2009 Oct 20
Branches: CGB
PubMedID: 19707196

Please tell us where you would like this free reprint sent.
(* = Required fields)

:
:
:
:
:
:
:
:
:
: